Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors-Reference-Cited by-同舟云学术

Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors

Published:2022-12-08 Issue:S2 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

McAleer Mary Frances¹^ORCID,Melchior Patrick²,Parkes Jeannette³⁴^ORCID,Pater Luke⁵,Rübe Christian²,Saunders Daniel⁶^ORCID,Paulino Arnold C.¹^ORCID,Janssens Geert O.⁷⁸,Kalapurakal John⁹

Affiliation:

1. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Radiation Oncology Saarland University Hospital Homburg Germany

3. Department of Radiation Oncology Groote Schuur Hospital and University of Cape Town Cape Town South Africa

4. Low‐ and Middle‐Income Countries Committee Co‐Chair Paediatric Radiation Oncology Society Cape Town South Africa

5. Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA

6. The Christie Foundation Trust Manchester England

7. Department of Radiation Oncology University Medical Center Utrecht Utrecht The Netherlands

8. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

9. Department of Radiation Oncology Feinberg School of Medicine Northwestern University Chicago Illinois USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.30090

Reference52 articles.

1. Incidence of childhood renal tumours: An international population‐based study

2. Wilms tumor;Pater L;Pediatr Blood Cancer,2021

3. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry

4. Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial

5. Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Toxicities among Wilms Tumor Survivors;Radiation Therapy;2023-11-08